| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/25/1996 | CA2202474A1 Materials for the production of nanometer structures and use thereof |
| 04/25/1996 | CA2202373A1 Preparation of frozen fermented foods using antifreeze polypeptide-expressing microorganisms |
| 04/25/1996 | CA2202283A1 Polycystic kidney disease gene |
| 04/25/1996 | CA2202048A1 Screening assay for anti-hiv drugs |
| 04/25/1996 | CA2201399A1 Defective adenoviruses including a therapeutic gene and an immunoprotective gene |
| 04/24/1996 | EP0708180A2 Improved, inductionless process for the genetical preparation of glutarylamidase |
| 04/24/1996 | EP0708179A2 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| 04/24/1996 | EP0708178A1 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy |
| 04/24/1996 | EP0707660A1 Method for generation of sequence sampled maps of complex genomes |
| 04/24/1996 | EP0707659A1 Salmonella identification by the polymerase chain reaction |
| 04/24/1996 | EP0707654A1 $i(BACILLUS THURINGIENSIS) TRANSPOSON Tn5401 AND ITS USE IN A SITE-SPECIFIC RECOMBINATION SYSTEM FOR $i(BACILLUS THURINGIENSIS) STRAIN DEVELOPMENT |
| 04/24/1996 | EP0707653A1 Method for specific silencing of genes by dna methylation |
| 04/24/1996 | EP0707652A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof |
| 04/24/1996 | EP0707651A1 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA) |
| 04/24/1996 | EP0707650A1 Process for producing relaxin |
| 04/24/1996 | EP0707649A1 Cisplatin resistance gene and uses therefor |
| 04/24/1996 | EP0707648A1 Platelet glycoprotein v gene and uses |
| 04/24/1996 | EP0707647A1 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
| 04/24/1996 | EP0707646A1 Vectors for genetically engineered cells that produce insulin in response to glucose |
| 04/24/1996 | EP0707645A1 Novel, recombinantly produced spider silk analogs |
| 04/24/1996 | EP0707644A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 04/24/1996 | EP0707641A1 An enzyme with protease activity |
| 04/24/1996 | EP0707640A1 (1 $m(7) 3, 1 $m(7) 4)-$g(b)-GLUCANASE OF ENHANCED STABILITY |
| 04/24/1996 | EP0707639A1 Chrysanthemyl diphosphate synthase, corresponding genes and use in pyrethrin synthesis |
| 04/24/1996 | EP0707638A1 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/24/1996 | EP0707634A1 New stromal cell lines from human bone marrow and their use |
| 04/24/1996 | EP0707599A1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 04/24/1996 | EP0707598A1 Human spasmolytic polypeptide in glycosylated form |
| 04/24/1996 | EP0707597A1 ANTIGENIC POLYPEPTIDES OF $i(T. OVIS) AND VACCINES CONTAINING SUCH POLYPEPTIDES |
| 04/24/1996 | EP0707591A1 Methylphosphonic acid ester, process for preparing the same and its use |
| 04/24/1996 | EP0707590A1 Dideoxyfructonucleotides and deoxyfructonucleotides as dna polymerase substrates |
| 04/24/1996 | EP0707496A1 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN inhA GENE |
| 04/24/1996 | EP0707493A1 Inhibitors and target molecule co-localization |
| 04/24/1996 | EP0670670A4 Transgenic cotton plants producing heterologous peroxidase. |
| 04/24/1996 | EP0625194B1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
| 04/24/1996 | EP0625006A4 Transgenic cotton plants producing heterologous bioplastic. |
| 04/24/1996 | EP0550693B1 Direct cloning of pcr amplified nucleic acids |
| 04/24/1996 | EP0490951B1 Fragments of nucleic acids derived from an appropriate mycobacteria genome, their applications in the diagnosis of mycobateria infections and plasmides containing said fragments |
| 04/24/1996 | CN1121357A Hepatitis B escape mutant specific binding molecules |
| 04/24/1996 | CN1121356A Use of tomato E8-derived promoters to express heterologous genes, E.G. 5-adenosylmethionine hydrolase, in ripening fruit |
| 04/24/1996 | CN1121355A Variants of bile salt-stimulated lipase, DNA molecules encoding them, and transgenic non-human mammals |
| 04/24/1996 | CN1121312A Chlamydia vaccine and process |
| 04/24/1996 | CN1031649C High-voltage discharge gene bombarder |
| 04/23/1996 | US5511159 Method of identifying parameterized matches in a string |
| 04/23/1996 | US5510475 Attachment of reporters by way of phosphonamidate linkers, having protected hydroxyl or amino functionality |
| 04/23/1996 | US5510474 Plant ubiquitin promoter system |
| 04/23/1996 | US5510473 Cloning of the recA gene from thermus aquaticus YT-1 |
| 04/23/1996 | US5510472 Production of recombinant human interferon-beta2 |
| 04/23/1996 | US5510471 Herbicide tolerance |
| 04/23/1996 | US5510466 Scavenger receptor protein and antibody thereto |
| 04/23/1996 | US5510462 IL-1βprotein precursor |
| 04/23/1996 | US5510461 pp: A newly identified CD45-associated protein |
| 04/23/1996 | US5510459 Glucagon antagonists |
| 04/23/1996 | US5510259 Isolated, purified dna having nucleotide sequence coding for said molecule |
| 04/23/1996 | US5510256 Genetically engineered dna sequences which do not code for a lymphocyte membrane polypeptide |
| 04/23/1996 | US5510255 Plant fatty acid synthases |
| 04/23/1996 | US5510253 Dna sequences |
| 04/23/1996 | US5510249 Fusion of signal peptide, a leader peptide, a heterogenous protein or polypeptide; genetic engineering |
| 04/23/1996 | US5510240 Method of screening a peptide library |
| 04/23/1996 | US5510239 One of the intersugar linkages between nuclotide units of the oligonuclotide is phosphorothioate linkage |
| 04/23/1996 | US5510099 Exposing transgenic mouse to test agent, recovering sample of test dna sequence, determining frequency of mutation by bioassay in prolysogenic escherichia coli |
| 04/23/1996 | CA1338260C Human protein s, a plasma protein regulator of hemostasis |
| 04/20/1996 | CA2160861A1 Induction-free process for the recombinant preparation of glutarylamidase |
| 04/19/1996 | CA2160753A1 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| 04/19/1996 | CA2138425A1 Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy |
| 04/18/1996 | WO1996011280A1 Attenuated viruses and method of making the same |
| 04/18/1996 | WO1996011279A2 Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system |
| 04/18/1996 | WO1996011278A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | WO1996011277A1 Microorganisms as therapeutic delivery systems |
| 04/18/1996 | WO1996011276A1 Method, reagent and kit for evaluating susceptibility to premature atherosclerosis and treatment of same using gene therapy |
| 04/18/1996 | WO1996011275A1 Cytoplasmic tyrosine kinase |
| 04/18/1996 | WO1996011274A1 Chimeric papillomavirus-like particles |
| 04/18/1996 | WO1996011273A1 Papillomavirus vaccine |
| 04/18/1996 | WO1996011272A2 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 04/18/1996 | WO1996011271A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/18/1996 | WO1996011270A1 Cloning and characterizing of genes associated with long-term memory |
| 04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |
| 04/18/1996 | WO1996011268A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/18/1996 | WO1996011267A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 04/18/1996 | WO1996011266A2 Method for inhibiting smooth muscle cell proliferation and oligonucleotides for use therein |
| 04/18/1996 | WO1996011265A1 Cis-acting sequences for intracellular localization of rna |
| 04/18/1996 | WO1996011263A1 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria |
| 04/18/1996 | WO1996011262A1 An enzyme and enzyme preparation with endoglucanase activity |
| 04/18/1996 | WO1996011261A1 Sorbitol kinase, process for producing the same, and substantially pure microorganism |
| 04/18/1996 | WO1996011260A1 Patched genes and their use |
| 04/18/1996 | WO1996011214A1 Peptides and pharmaceutical compositions comprising them |
| 04/18/1996 | WO1996011212A1 Novel receptor-type tyrosine kinase ligand |
| 04/18/1996 | WO1996011211A1 Selective inhibition of internally initiated rna translation |
| 04/18/1996 | WO1996011020A1 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 04/18/1996 | WO1996011013A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 04/18/1996 | WO1996011010A1 Bridged and unbridged quadruplex/duplex oligonucleotides |
| 04/18/1996 | WO1996010997A1 Hepatitis virus vaccines |
| 04/18/1996 | WO1996010911A1 Cytokine designated lerk-6 |
| 04/18/1996 | WO1996007739A3 Interleukin-1 type 3 receptors |
| 04/18/1996 | WO1996001317A3 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 04/18/1996 | DE4436665A1 Prepn. of Rep-negative adeno-associated virus mutants |
| 04/18/1996 | DE19507166C1 Antibodies specific for fusion polypeptide(s) contg. a histidine component |
| 04/18/1996 | CA2202088A1 Hepatitis virus vaccines |
| 04/18/1996 | CA2202066A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | CA2201935A1 Peptides and pharmaceutical compositions comprising them |